Company Overview
Aidma Holdings is a small-cap Tokyo Stock Exchange Growth company that sells outsourced sales support, sales-tech tools, and remote-worker-enabled business support to Japanese small and mid-sized businesses. In plain English, it helps clients find prospects, run outbound sales, manage lead data, and supplement labor shortages without hiring a full in-house team.
Data freshness matters here. The latest clean official annual base is FY2025, the year ended August 2025, using audited annual report data. More recent numbers exist, but they are unaudited FY2026 quarterly disclosures. The latest one is the 9M FY2026 update disclosed on July 10, 2026. Under Japan’s newer disclosure regime, Q1 and Q3 rely more on earnings releases than old-style quarterly filings, so they are useful but not equivalent to an audited annual base.
| Core item | Value | Classification |
|---|---|---|
| Market cap | About ¥17.2bn | Market-data snapshot around July 13, 2026 |
| Net cash | About ¥5.2bn | Audited FY2025 annual data; cash less interest-bearing debt |
| Net income, TTM | About ¥1.58bn | Own estimate: FY2025 Q4 audited plus FY2026 Q1-Q3 unaudited quarter data |
| Current P/E | About 10.9x | Own estimate: current price divided by assembled TTM EPS |
| Normalized / trough-aware P/E | About 14.3x | Own estimate: current price divided by revised FY2026 company guidance EPS of ¥81.01 |
The balance sheet is not the problem. FY2025 audited cash was ¥5.35bn, debt was only about ¥0.13bn, and the equity ratio was 66%. The latest Q3 FY2026 disclosure still shows a very strong equity ratio of 73%. If this stock is mispriced, it is because the market is debating future earning power and moat quality, not solvency.
How the Company Makes Money
The profit engine is the sales support business. In FY2025, sales support produced about ¥8.8bn of revenue, or roughly 66% of the total. Human-resource support, mainly built around remote-worker utilization and related support, contributed about ¥3.9bn, or roughly 30%. Other services were only about 4%. So this is not really a diversified mini-conglomerate. The economics still hinge on whether Aidma can profitably convert client demand for outsourced sales execution into recognized revenue at good margins.
The company’s pitch is attractive to SMEs: it combines lead lists, sales workflow tools, outbound execution, remote workers, and process consulting into one service. That has historically produced an unusually good model for a small-cap service firm: high gross margins, modest capital intensity, and strong cash generation when working capital behaves.
Growth. Using audited annual data, revenue rose from ¥6.2bn in FY2022 to ¥13.3bn in FY2025, a 3-year CAGR of about 29%. Net income rose from ¥1.04bn to ¥1.95bn, a 3-year CAGR of about 24%. EPS compounded at roughly the same rate. The two concrete growth drivers were: first, more SMEs outsourcing sales and back-office work; second, deeper wallet share from cross-selling more support “units” and human-resource support into the installed customer base.
Owner earnings sanity check. On the FY2025 audited base, net income was ¥1.95bn. If one subtracts rough sustaining capex of ¥0.1-0.15bn and also penalizes the year for a material working-capital use of roughly ¥0.4-0.6bn, rough owner earnings land around ¥1.3-1.5bn. At today’s market cap of about ¥17.2bn, that is an owner-earnings yield of roughly 8-9%. That is somewhat less attractive than the raw FY2025 earnings history suggests, but still better than the headline impression of a broken business. It is not wildly different from the P/E if one uses FY2025 as the base; it becomes more different only when one uses the newly cut FY2026 guidance.
Capital efficiency. Reported ROE has been consistently high: about 29% in FY2022, 27% in FY2023, 24% in FY2024, and 28% in FY2025. That is excellent, though part of it comes from an asset-light model rather than an impregnable moat. Incremental capital has also looked good: equity increased by roughly ¥3.2bn from FY2022 to FY2025, while net income increased by roughly ¥0.9bn. That suggests incremental capital has earned strong returns, but not enough to prove a fortress franchise.
Business quality. Where do profits actually come from? Mostly from monetizing sales execution and workflow support, not from a pure software subscription model with obvious recurring economics. Why has it been a good business? Because Aidma built a useful bundle: historical sales know-how, a large corporate database, remote-worker operations, and cross-sell into adjacent support services. The advantage is real, but it is a soft moat: process, data, and distribution rather than regulation, switching costs, or deep proprietary technology.
Why the Stock Fell
The stock is near a 52-week low because the market stopped believing the FY2026 growth algorithm. Around mid-July 2026, the shares were trading roughly in the ¥1,150-1,190 range, versus a 52-week high near ¥3,255 and a low around ¥1,130. That is a decline of roughly 65% from the high.
The immediate trigger was the July 10, 2026 third-quarter disclosure. Management cut full-year FY2026 guidance from ¥17.0bn to ¥14.0bn of revenue, from ¥4.0bn to ¥2.2bn of operating profit, and from ¥2.3bn to ¥1.2bn of net income. That is not a rounding error. It is a major reset.
The numbers explain why investors reacted so sharply. H1 FY2026 operating profit was only ¥1.52bn, or 38% of the old full-year operating-profit guide. After 9M FY2026, cumulative operating profit was ¥1.85bn. To hit the old ¥4.0bn guide, Aidma would have needed roughly ¥2.15bn of Q4 operating profit alone, versus only about ¥0.80bn in FY2025 Q4. The market was not merely discounting a weaker quarter. It was discounting a loss of forecast credibility.
Management’s stated reason was lower conversion of orders into recognized revenue due to changing customer mix. That matters. Investors are not looking at a random expense spike. They are asking whether Aidma’s core earnings engine has become less efficient and less predictable.
The same announcement included a buyback authorization of up to 450,000 shares or ¥0.9bn. That is a positive signal, but it does not by itself fix a broken forecast process.
What the Market Is Assuming
(a) One-time, cyclical, or sentiment-driven factors
- The July 2026 guidance cut was a forecast-credibility shock.
- The stock is a small-cap Growth-market name with limited float, so deratings are violent.
- Part of the problem is timing: orders are not converting into revenue as quickly as investors expected.
- The market may also be reacting to sentiment after a long de-rating, not only to fundamentals.
(b) Medium-term business headwinds
- Revenue conversion from backlog to booked sales has weakened.
- Customer mix has shifted toward renewals and additional units with lower revenue yield.
- Lead times to service start have lengthened.
- Management reallocated resources toward customer support, which may have helped retention but hurt new-sales productivity.
- Quarterly margins have compressed sharply.
(c) Potential long-term structural threats
- The moat may be softer than the historical ROE suggests.
- AI can commoditize list building, scripting, outreach, and some support workflows.
- SME customers are price sensitive and may not tolerate premium pricing if differentiation narrows.
- The business is still centered on sales support, so a lasting deterioration there would matter disproportionately.
- The company itself acknowledges that entry barriers are not especially high.
Temporary or Structural?
Reality check first: the market narrative of demand collapse goes too far. Revenue has not fallen off a cliff. It grew from ¥6.2bn in FY2022 to ¥9.1bn in FY2023, ¥10.6bn in FY2024, and ¥13.3bn in FY2025. Even in the troubled latest period, 9M FY2026 revenue was still up 12.6% year over year. The problem is not vanishing top-line demand. The problem is that conversion, monetization, and margins have weakened at the same time.
There is also no balance-sheet fragility narrative to support a permanent-impairment case. Operating cash flow was ¥1.74bn in FY2022, ¥2.18bn in FY2023, ¥1.19bn in FY2024, and ¥2.48bn in FY2025. Leverage stayed trivial. Equity ratio moved from roughly 62% in FY2022 to 66% in FY2025 and 73% in Q3 FY2026. This is an earnings-quality debate, not a balance-sheet rescue case.
| Concern | Quantitative reality check | Damaged mechanism | Reversible within 3 years? | Classification |
|---|---|---|---|---|
| Demand collapse | Revenue grew from ¥6.2bn in FY2022 to ¥13.3bn in FY2025. 9M FY2026 revenue still rose 12.6% YoY. H1 FY2026 total order volume was reported up 32.9% YoY. | Not the core mechanism. The top of the funnel still exists. | Yes. In fact, this does not look broken now. | (c) Not truly structural |
| Order-to-revenue conversion and lower revenue yield per order | Management indicated backlog revenue-recognition rate moving from 53% to 46%. H1 FY2026 orders rose strongly, but H1 revenue grew only 16.1%. FY2026 guide was cut from ¥17.0bn to ¥14.0bn. | The order-to-revenue conversion funnel. More contracts are starting later or monetizing less efficiently. | Probably yes. This is operationally fixable and not capital intensive, but it is not self-healing. | (b) Real structural but survivable |
| Margin compression and weaker unit economics | Operating margin was 26.5% in FY2022, 24.4% in FY2023, 23.2% in FY2024, and 23.4% in FY2025. But standalone Q3 margin fell from 24.4% in FY2025 Q3 to 9.1% in FY2026 Q3. | Price realization and operating leverage in the core service model. | Partly. If customer mix normalizes, yes. If lower-priced add-on units become the norm, margins may settle lower. | (b) Real structural but survivable |
| AI and low-barrier competition | The company still posted high ROE and growth through FY2025, so erosion is not yet proven in the historical numbers. But no SaaS-style ARR or churn disclosure exists, and management itself admits barriers are not especially high. | Differentiation and pricing power of the sales-support platform. | Only partly. This can be mitigated by better execution, data, and workflow integration, but not wished away. | (b) Real structural but survivable |
| Balance-sheet stress | FY2025 cash was ¥5.35bn against only about ¥0.13bn of debt. Q3 FY2026 equity ratio was 73%. | None. The balance sheet is not damaged. | Not applicable. | (c) Not truly structural |
Bottom line: the immediate earnings damage is mostly TIME, not pure ESSENCE. But the episode also exposes a real essence risk: this is a softer-moat business than the historical margin and ROE profile made it look. The market is right to question durability. It is too early to say the core value-creation mechanism is permanently impaired.
Is the Market Wrong? By How Much?
Time-as-a-moat test. If I had the company’s current market capitalization in cash, I could build a credible competing tool stack and service operation within 2 years. I could hire sales operators, buy data, build CRM-like functionality, and subsidize customer acquisition. What I could not easily replicate that fast is Aidma’s accumulated campaign data, client references, cross-sell playbook, and remote-worker operating muscle.
- 2 years: A credible competitor is realistic. Full replication is not.
- 5 years: Probably yes. A determined rival or consolidator could get close.
- 10 years: Definitely yes. This is rebuildable.
What still blocks a fast rebuild is not regulation or deep proprietary tech. It is trust, operational know-how, process data, and a working ecosystem of clients and remote workers. That is a moat, but only a moderate one.
Moat & mispricing score: 6/10. The market is right that the moat is softer than historical ROE suggested and that management damaged credibility with an over-optimistic FY2026 plan. The market is probably wrong if it is pricing FY2026’s conversion problem as a permanent ceiling on earning power. This still looks like a cash-rich, asset-light, double-digit grower with a bruised earnings algorithm, not a franchise in terminal decline. The stock is not obviously a 10/10 mispricing because the business is rebuildable and competitive pressure is real.
Valuation basis: this is a FY2025-based valuation adjusted with 9M FY2026 updates and the revised FY2026 company guidance. I am valuing the equity on owner earnings, then adding audited FY2025 net cash. I am not relying on multiple expansion as the main thesis.
| Case | Owner earnings / normalized earnings base | Assumed equity yield | Net cash adjustment | Implied equity value | Implied value per share | Vs. current price (~¥1,156) |
|---|---|---|---|---|---|---|
| Bear | ¥1.0bn Assumes FY2026 weakness is mostly real and margins stay well below FY2025 |
10.0% | + ¥5.2bn | About ¥15.2bn | About ¥1,020/share | About -12% |
| Base | ¥1.4bn Assumes partial recovery from the FY2026 trough, but not a return to peak optimism |
8.0% | + ¥5.2bn | About ¥22.7bn | About ¥1,530/share | About +32% |
| Bull | ¥1.8bn Assumes conversion normalizes and FY2025-like earning power proves mostly intact |
7.5% | + ¥5.2bn | About ¥29.2bn | About ¥1,965/share | About +70% |
At the current market cap, the stock implies roughly a 7.0% earnings yield on revised FY2026 company guidance and about an 8.1% yield on my base normalized owner-earnings estimate. Strip out the audited net cash and the operating business is being valued at roughly ¥12bn, or only about 5.5x revised FY2026 operating-profit guidance. That is why I think the market may be somewhat too negative, though not irrationally so.
Key Facts, Estimates, and Judgments
| Item | Value | Type | Comment |
|---|---|---|---|
| Latest clean annual base | FY2025 | Audited annual data | Year ended August 2025 |
| Latest official update | 9M FY2026, disclosed July 10, 2026 | Unaudited quarterly data | Useful, but not equivalent to audited annual data |
| Current share price | About ¥1,156 | Market-data estimate | Used for current valuation math |
| Current market cap | About ¥17.2bn | Market-data estimate | Based on current price and latest treasury-excluded share count |
| Net cash | About ¥5.2bn | Audited annual data | FY2025 cash less debt; current Q3 cash was not separately disclosed in the summary |
| TTM net income | About ¥1.58bn | Own estimate | Built from FY2025 Q4 plus FY2026 Q1-Q3 quarter results |
| Current P/E | About 10.9x | Own estimate | I prefer this to stale market-data TTM figures |
| Normalized / trough-aware P/E | About 14.3x | Own estimate using company guidance | Uses revised FY2026 EPS guidance of ¥81.01 |
| Owner earnings | About ¥1.3-1.5bn on FY2025 base | Own estimate | Depends on maintenance capex and working-capital treatment |
| Main judgment | Mostly TIME, with some ESSENCE risk exposed | Judgment | The earnings hit looks more reversible than the stock suggests, but the moat is not deep |
| Structural conclusion | Soft moat, rebuildable business | Judgment | Moderate edge in data, process, and trust; not a fortress |
| Intrinsic value range | ¥15.2bn to ¥29.2bn equity value ¥1,020 to ¥1,965 per share |
Own estimate | Bear / base / bull, not a price target |
The cleanest way to read Aidma today is this: the stock fell because the market no longer trusts the company’s near-term earnings conversion, not because the balance sheet broke or demand vanished. That makes it a repairable but not trivial problem. If you need a fortress moat, pass. If you can tolerate a soft-moat operator with real cash, strong historical economics, and a bruised but not destroyed franchise, the current price looks modestly mispriced on the downside.